Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.	Fin. Year	Received	Resolved*
1	2021-22	1	1
2	2022-23	1	1
3	2023-24	0	0
4	2024-25	0	0
	Grand Total	2	2

Top Pharma Companies in India by Market Cap

BSE Sensex 72382.47 472.77 (0.66%)

Filter

Top Pharma Companies in India as on Oct-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
1	Sun Pharmaceutical Industries Ltd.	Q V+ PT	4,27,562 Large Cap	1,782 (-1.55%)	35.35	4.94	11.78	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Divis Laboratories Ltd.	Q V+ PT	2,44,572 Large Cap	9,212.85 (-0.88%)	83.61	13.85	8.67	4.44	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Torrent Pharmaceuticals Ltd.	Q V+ PT	1,80,871 Large Cap	4,755.15 (-0.14%)	82.93	20.15	11.80	13.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Apollo Hospitals Enterprise Ltd.	Q V+ PT	1,15,172 Large Cap	8,010 (-1.31%)	73.31	11.17	14.92	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Zydus Lifesciences Ltd.	Q V PT	1,13,566 Mid Cap	1,138.50 (-0.59%)	25.16	4.21	13.52	14.72	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Cipla Ltd.	Q V PT	1,07,770 Large Cap	1,334 (-0.95%)	31.97	3.07	8.01	10.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Laurus Labs Ltd.	Q V+ PT	1,06,117 Mid Cap	1,964 (-1.26%)	97.06	18.82	7.19	-2.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Mankind Pharma Ltd.	Q V PT	1,02,433 Mid Cap	2,479.95 (-1.86%)	50.15	6.09	18.10	8.40	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Dr. Reddys Laboratories Ltd.	Q V PT	1,00,829 Mid Cap	1,208 (0.66%)	31.29	2.64	12.09	15.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Aurobindo Pharma Ltd.	Q V+ PT	96,088 Mid Cap	1,670 (-0.30%)	37.06	4.1	-6.73	-4.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Lupin Ltd.	Q V PT	91,915 Mid Cap	2,010 (-0.94%)	16.62	3.86	13.02	32.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Max Healthcare Institute Ltd.	Q V PT	89,214 Mid Cap	916.60 (-2.99%)	61.23	8.16	27.27	155.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Manipal Health Enterprises Ltd.	Q V+ PT	87,775 Mid Cap	667.30 (-4.09%)	98.37	4.81	41.64	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Glenmark Pharmaceuticals Ltd.	Q V+ PT	64,392 Mid Cap	2,281.60 (-2.34%)	35.82	5.87	9.19	22.19	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Alkem Laboratories Ltd.	Q V PT	61,825 Mid Cap	5,170.85 (-1.32%)	28.66	4.32	10.66	8.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Biocon Ltd.	Q V PT	60,258 Mid Cap	369.75 (-0.31%)	616.76	2.23	2.96	-18.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Aster DM Quality Care Ltd.	Q V+ PT	60,233 Mid Cap	691 (-2.50%)	189.01	14.24	-11.61	19.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Fortis Healthcare Ltd.	Q V+ PT	57,754 Mid Cap	765 (-2.66%)	55.11	5.68	17.76	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Abbott India Ltd.	Q V PT	55,908 Mid Cap	26,310.45 (-1.94%)	34.62	10.8	9.96	17.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	Ipca Laboratories Ltd.	Q V+ PT	49,507 Mid Cap	1,951.35 (0.57%)	39.8	5.93	7.35	1.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Gland Pharma Ltd.	Q V PT	48,068 Mid Cap	2,913 (1.37%)	42.58	4.52	13.18	0.09	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Anthem Biosciences Ltd.	Q V PT	48,010 Mid Cap	851.95 (-0.25%)	83.36	15.34	14.00	16.46	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Glaxosmithkline Pharmaceuticals Ltd.	Q V PT	46,320 Mid Cap	2,734.25 (-1.45%)	43.36	18.38	5.49	17.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Ajanta Pharma Ltd.	Q V+ PT	43,591 Mid Cap	3,488.40 (-2.62%)	38.41	8.97	13.54	10.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	Emcure Pharmaceuticals Ltd.	Q V PT	36,778 Small Cap	1,938.65 (-0.25%)	36.36	7.03	8.73	13.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	Global Health Ltd.	Q V PT	35,806 Small Cap	1,331.70 (-1.94%)	64.38	8.71	24.97	76.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Narayana Hrudayalaya Ltd.	Q V PT	35,189 Mid Cap	1,721.90 (-1.15%)	43.12	7.41	25.04	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Wockhardt Ltd.	Q V+ PT	33,499 Small Cap	2,061.60 (-1.19%)	81.91	6.65	4.49	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Dr. Lal Pathlabs Ltd.	Q V PT	33,078 Small Cap	1,970.70 (-1.79%)	60.72	12.86	12.18	13.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	Sai Life Sciences Ltd.	Q V+ PT	32,112 Small Cap	1,511.75 (-1.83%)	88.77	12.58	23.61	39.96	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Shukra Pharmaceut.	70.15	13.44%
Kilitch Drugs(India)	233.50	8.08%
Metropolis Health.	555.10	3.18%
One Global Service	543.20	2.96%
NGL Fine-Chem	3,009.65	2.88%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Gaudium IVF & Women	102.70	-6.42%
Windlas Biotech	1,018	-6.02%
Solara Active Pharma	676.50	-5.52%
Suraksha Diagnostic	331.05	-5.48%
Anlon Healthcare	31.31	-4.98%

News about Top Pharma Companies in India

Oct, 2026

Aurobindo Pharma rises on getting USFDA’s final nod to manufacture, market Perampanel tablets

The product will be manufactured at Unit-IV of APL Healthcare, a wholly-owned subsidiary of the company and will be launched in Q3FY27

Oct, 2026

Aurobindo Pharma gets USFDA’s final nod to manufacture, market Perampanel tablets

The product will be manufactured at Unit-IV of APL Healthcare, a wholly-owned subsidiary of the company and will be launched in Q3FY27

Oct, 2026

Aurobindo Pharma informs about acquisition

Aurobindo Pharma has informed that this is with refer to letters dated July 23, 2026, September 12, 2026 and October 01, 2026, informing that Apitoria Pharma Private Limited (Apitoria), a wholly owned subsidiary of the Company, is acquiring the Contract Research Services business of A1 Biochem Group. A1 Biochem USA Inc (A1 USA Inc), which is a wholly owned subsidiary of A1 Biochem Labs (India) Private Limited (A1 Labs India), has acquired 100% ownership of A1 Biochem Labs LLC (A1 Labs LLC) in accordance with the terms of the Definitive Agreements entered into for the acquisition of A1 Biochem Group. A1 Labs LLC is operating from USA and will now be a step-down subsidiary of A1 Labs India. The disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Part A of Schedule III of the aforesaid regulations, is attached as Annexure A.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Abbott India informs about newspaper advertisement

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, and in compliance with the Circular issued by Securities and Exchange Board of India dated January 30, 2026, Abbott India has informed that it enclosed the newspaper advertisement, pertaining to the opening of special window for transfer and dematerialization of physical securities, published in the Business Standard (All Editions) and Loksatta today, Friday, October 2, 2026.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Sai Life Sciences submits board meeting intimation

Sai Life Sciences has informed that pursuant to Regulation 29(1) of the SEBI Listing Regulations, a meeting of Board of Directors of the Company is scheduled to be held on Thursday, 05th November 2026, to consider and approve: 1. The standalone and consolidated unaudited financial results of the Company for the second quarter and half year ended September 30, 2026; and 2. Other corporate matters. As informed by our communication letter dated 28th September 2026, the trading window for dealing in the securities of the Company was closed for all designated persons and their immediate relatives from 01st October 2026 and shall remain closed till 48 hours after the announcement of financials results i.e. up to 07th November 2026.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Gland Pharma informs about disclosure

Gland Pharma has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fosun Pharma Industrial.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Sun Pharmaceutical Industries Ltd.	4,27,562 Crore
2	Divis Laboratories Ltd.	2,44,572 Crore
3	Torrent Pharmaceuticals Ltd.	1,80,871 Crore
4	Apollo Hospitals Enterprise Ltd.	1,15,172 Crore
5	Zydus Lifesciences Ltd.	1,13,566 Crore
6	Cipla Ltd.	1,07,770 Crore
7	Laurus Labs Ltd.	1,06,117 Crore
8	Mankind Pharma Ltd.	1,02,433 Crore
9	Dr. Reddys Laboratories Ltd.	1,00,829 Crore
10	Aurobindo Pharma Ltd.	96,088 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	26,310	55,908	34.62	10.80	23.74	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,755	1,80,871	82.93	20.15	37.97	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,282	64,392	35.82	5.87	11.94	27.89
Lupin Ltd. (M)	Somewhat Good	2,010	91,915	16.62	3.86	9.20	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,488	43,591	38.41	8.97	25.95	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,964	1,06,117	127
Sai Life Sciences Ltd. (S)	Somewhat Good	1,512	32,112	71.11
Divis Laboratories Ltd. (L)	Very Good	9,213	2,44,572	57.03
Aurobindo Pharma Ltd. (M)	Very Good	1,670	96,088	52.71
Gland Pharma Ltd. (M)	Very Good	2,913	48,068	49.18
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,512	32,112	88.77	12.58	45.79	23.61
Mankind Pharma Ltd. (M)	Very Good	2,480	1,02,433	50.15	6.09	26.01	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,488	43,591	38.41	8.97	25.95	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,139	1,13,566	25.16	4.21	14.12	13.52
Gland Pharma Ltd. (M)	Very Good	2,913	48,068	42.58	4.52	21.70	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,512	32,112	88.77	12.58	45.79	39.96
Lupin Ltd. (M)	Somewhat Good	2,010	91,915	16.62	3.86	9.20	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,282	64,392	35.82	5.87	11.94	22.19
Abbott India Ltd. (M)	Very Good	26,310	55,908	34.62	10.80	23.74	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,208	1,00,829	31.29	2.64	16.03	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Current Complaints

^ Average Resolution time is the sum total of time taken to resolve each complaint in days, in the current month divided by total number of complaints resolved in the current month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Aurobindo Pharma rises on getting USFDA’s final nod to manufacture, market Perampanel tablets

Aurobindo Pharma gets USFDA’s final nod to manufacture, market Perampanel tablets

Aurobindo Pharma informs about acquisition

Abbott India informs about newspaper advertisement

Sai Life Sciences submits board meeting intimation

Gland Pharma informs about disclosure

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?